A new report from the National Academies of Sciences, Engineering, and Medicine highlights the growing disconnect between state and federal regulations on cannabis, leading to emerging public health concerns. While more than half of US states have legalized cannabis for medical or recreational use, the federal government still considers most types of cannabis illegal. This disparity has resulted in fragmented policies and a lack of national standards for cannabis quality and potency.
The report emphasizes the need for federal leadership and national standards to safeguard public health. Here are five key takeaways:
1. Cannabis use has surpassed alcohol use in the US, with more adults reporting daily use in 2022 than in 1992. The increasing accessibility and affordability of cannabis have contributed to its growing popularity.
2. The potency of cannabis products has increased, with some containing as much as 60% to 90% THC. This has led to concerns about accidental overconsumption and related health issues.
3. Psychoactive hemp products, including CBD and delta-8 THC, can be sold in states where cannabis is illegal. These products have evaded regulation, despite potential health risks.
4. Research on cannabis is hindered by the drug’s Schedule I classification, which restricts access to the drug for studies. The report recommends reclassifying cannabis to facilitate research and address the lack of scientific knowledge on its health effects.
5. While cannabis has been legalized in many states, the public remains largely unaware of its potential risks, including psychosis, suicidal ideation, and cannabis use disorder. The report recommends public health campaigns to educate the public about the risks and benefits of cannabis use, particularly among vulnerable populations such as children and young adults.
The report’s findings highlight the need for a comprehensive approach to cannabis regulation, one that balances public health concerns with the growing demand for cannabis products. By addressing the gaps in research, regulation, and public awareness, policymakers can work to ensure a safer and more responsible cannabis market.
